Combined modality therapy for unresectable stage III non-small cell lung cancer: New chemotherapy combinations

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Combined modality therapy for unresectable stage III non-small cell lung cancer: New chemotherapy combinations'. Together they form a unique fingerprint.

Medicine & Life Sciences